An Evaluation of Weight Gain in Patients Treated with Dolutegravir vs. Other Core Agents (208943)

First published 11/01/2019

Last updated 02/07/2024

EU PAS number:

EUPAS27523

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

viiv-208943-protocol-redact

English (1.39 MB - PDF)View document

Study results

Study results

viiv-208943-clinical-study-report-redact

English (5.71 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents